Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TACROLIMUS Cause Lung neoplasm malignant? 92 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Lung neoplasm malignant have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.1% of all adverse event reports for TACROLIMUS.

92
Reports of Lung neoplasm malignant with TACROLIMUS
0.1%
of all TACROLIMUS reports
55
Deaths
22
Hospitalizations

How Dangerous Is Lung neoplasm malignant From TACROLIMUS?

Of the 92 reports, 55 (59.8%) resulted in death, 22 (23.9%) required hospitalization, and 4 (4.3%) were considered life-threatening.

Is Lung neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 92 reports have been filed with the FAERS database.

What Other Side Effects Does TACROLIMUS Cause?

Off label use (8,718) Drug ineffective (6,214) Product use in unapproved indication (5,057) Acute kidney injury (4,005) Transplant rejection (3,526) Cytomegalovirus infection (3,320) Covid-19 (3,201) Drug interaction (2,896) Diarrhoea (2,854) Toxicity to various agents (2,845)

What Other Drugs Cause Lung neoplasm malignant?

RANITIDINE (15,214) ADALIMUMAB (698) TIOTROPIUM (637) ETANERCEPT (612) METHOTREXATE (522) CLOZAPINE (440) APIXABAN (411) ALBUTEROL (403) INFLIXIMAB (379) BUDESONIDE\FORMOTEROL (353)

Which TACROLIMUS Alternatives Have Lower Lung neoplasm malignant Risk?

TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS TACROLIMUS vs TADALAFIL TACROLIMUS vs TAFAMIDIS TACROLIMUS vs TAFAMIDIS MEGLUMINE TACROLIMUS vs TAFASITAMAB

Related Pages

TACROLIMUS Full Profile All Lung neoplasm malignant Reports All Drugs Causing Lung neoplasm malignant TACROLIMUS Demographics